Activist Hedge Fund Trian Builds Stake in Unilever: FT (1)

Jan. 23, 2022, 1:22 PM UTC

Nelson Peltz’s activist hedge fund Trian Partners has built a stake in Unilever Plc, the Financial Times reported, potentially adding pressure on management after a failed bid to buy GlaxoSmithKline Plc’s consumer-health unit.

Unilever shares recorded their worst weekly loss since the peak of the pandemic selloff in March 2020 after it confirmed on Jan. 16 that it offered 50 billion-pounds ($68 billion) for the healthcare unit. GSK rejected the bid as too low. The Financial Times didn’t report details on the size of Trian’s stake building or when it began.

Unilever Chief Executive Officer Alan Jope’s public ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.